COSTA MESA, Calif., July 3, 2014 /PRNewswire-iReach/ -- WCCT Global (WCCTG), a full service contract research organization announced today that they have already achieved their 2014 goal to exceed 10,000 patient followers on Facebook and multiple other patient networks on other social media accounts. This achievement provides WCCTG a powerful network of patients to quickly enroll clinical trials for their ongoing studies. WCCT Global is one of the leading CRO's with such a broad patient network that also spans multiple social networks. They have seen substantial enrollment enhancements over the past 18 months due to their specialized social media initiative. They say that social media has enabled them to connect with many people who are not familiar with clinical trials and ultimately educate them over time to a comfortable level sufficient to have them join one of their clinical trials. With WCCTG having over 10,000 clinical trial volunteers on Facebook located in Southern California, they have the ability to instantly notify eager volunteers about new trials. To go a step further, with such a large following, WCCT Global is able to market through their followers to others who may be eligible for their studies as well. This equates to the CRO being able to reach more than 1 million people on Facebook alone.
Photo - http://photos.prnewswire.com/prnh/20140702/124162
WCCT Global also explained that they have been able to use social media to build a very large patient database including email, phone number, location, and patient profiles to be able to give clients instant notification access to patients eligible for their study. WCCT Global's Associate Director of Marketing, Matt Miller stated, "Establishing a strong social media connection for clinical research has been a fundamental tool to instantly enroll patients for clinical trials. The real power of building a large social following is to have a large amount of social media subscriber engagement to help spread the word about current clinical trials at our sites for patient recruitment."
WCCT Global implemented a vast patient recruitment service offering called "In-Site" to sponsors that are looking for an innovative way to find patients for their clinical trial sites. "In-Site" allows these technologies to be applied to multi-site recruitment campaigns along with the capabilities of WCCT Global special patient screening and patient targeting process. The solution they have developed is innovative in design and the most efficient way of recruiting patients for ongoing clinical trials. WCCT Global's "In-Site" also takes a "risk-free" approach requesting that clients only pay for patients that are enrolled into the targeted study. In this way, WCCT Global is able to provide top level service to the pharmaceutical industry and only succeed when their clients succeed.
More about WCCT Global:
WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, "With compassion for people, we strive for tomorrow's therapies to be available today" truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, recruitment services, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you are interested in learning more about WCCT Globals Patient Recruitment or Clinical Research capabilites, CLICK HERE and request information.
Media Contact:Matt Miller, WCCT Global, 714.668.1500 ext.2029, Matt.Miller@wcct.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global